Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Ani Pharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 116 | 2 | 118 | +4 |
| Shares | 7.21M | 383.7K | 7.28M | +451.4K (+6.6%) |
| Value | $252.7M | $13.4M | $238.8M | −$439.9K (−0.2%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Ani Pharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marathon Capital Management | 74,195 | $2.44M | 0.55% |
| Global Alpha Capital Management Ltd. | 64,432 | $2.12M | 0.23% |
| Mitsubishi UFJ Asset Management (UK) Ltd. | 16,000 | $525.0K | 0.22% |
| SG Americas Securities, LLC | 12,624 | $414.0K | 0.00% |
| HRT Financial LP | 8,064 | $264.0K | 0.00% |
| Millennium Management LLC | 7,076 | $232.0K | 0.00% |
| ExodusPoint Capital Management, LP | 6,345 | $208.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 5,151 | $168.9K | 0.00% |
| MetLife Investment Management | 3,731 | $122.5K | 0.00% |
| Metropolitan Life Insurance Co | 2,900 | $95.2K | 0.00% |
| ClariVest Asset Management LLC | 43 | $1.00K | 0.00% |
| Quadrant Capital Group LLC | 26 | $1.00K | 0.00% |
| Berman Capital Advisors, LLC | 53 | $1.00K | 0.00% |
| Meridian Wealth Partners, LLC | 44 | $1.00K | 0.00% |
| MCF Advisors LLC | 1 | $0 | 0.00% |
| Kowal Investment Group, LLC | 1 | $0 | 0.00% |
Sold out (12)
Institutions that held Ani Pharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Cornercap Investment Counsel Inc | 36,818 | $1.29M |
| Hussman Strategic Advisors, Inc. | 30,400 | $1.07M |
| AQR Capital Management LLC | 19,542 | $685.0K |
| Engineers Gate Manager LP | 8,411 | $295.0K |
| Jump Financial, LLC | 6,700 | $235.0K |
| Manufacturers Life Insurance Company, The | 6,377 | $224.0K |
| Acadian Asset Management LLC | 3,455 | $121.0K |
| Parkside Financial Bank & Trust | 155 | $5.00K |
| Massmutual Trust Co FSB | 48 | $2.00K |
| Versant Capital Management, Inc | 40 | $1.00K |
| FMR LLC | 12 | $0 |
| McClarren Financial Advisors, Inc. | 3 | $0 |
Not filed for Q3 2021 yet (2)
Institutions that held Ani Pharmaceuticals Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Investment Counselors of Maryland LLC | 383,696 | $13.4M |
| CWM, LLC | 5 | $0 |